SI-BONE, Inc. (SIBN)
USD 13.71
(-4.53%)
USD 13.71
(-4.53%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -34.44 Million USD | 28.98% |
| 2022 | -54.98 Million USD | -14.12% |
| 2021 | -49.58 Million USD | -36.2% |
| 2020 | -36.46 Million USD | -12.38% |
| 2019 | -32.68 Million USD | -179.6% |
| 2018 | -11.62 Million USD | 24.38% |
| 2017 | -15.82 Million USD | 2.59% |
| 2016 | -16.24 Million USD | 36.64% |
| 2015 | -25.68 Million USD | 1.45% |
| 2014 | -26.01 Million USD | -395.79% |
| 2013 | -5.24 Million USD | 50.86% |
| 2012 | -10.67 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -10.95 Million USD | -4.86% |
| 2024 Q2 | -9.08 Million USD | 20.9% |
| 2023 Q2 | -10.35 Million USD | -0.67% |
| 2023 Q1 | -10.28 Million USD | 0.07% |
| 2023 Q4 | -10.93 Million USD | -19.64% |
| 2023 FY | - USD | 28.98% |
| 2023 Q3 | -9.13 Million USD | 11.76% |
| 2022 Q2 | -17.89 Million USD | -10.88% |
| 2022 Q3 | -13.4 Million USD | 25.09% |
| 2022 Q4 | -10.29 Million USD | 23.2% |
| 2022 FY | - USD | -14.12% |
| 2022 Q1 | -16.13 Million USD | -16.02% |
| 2021 Q4 | -13.9 Million USD | -5.25% |
| 2021 Q3 | -13.21 Million USD | -2.39% |
| 2021 Q1 | -11.17 Million USD | -41.6% |
| 2021 FY | - USD | -36.2% |
| 2021 Q2 | -12.9 Million USD | -15.46% |
| 2020 Q4 | -7.89 Million USD | 2.43% |
| 2020 Q3 | -8.09 Million USD | 17.35% |
| 2020 FY | - USD | -12.38% |
| 2020 Q1 | -11.29 Million USD | -43.76% |
| 2020 Q2 | -9.78 Million USD | 13.31% |
| 2019 Q4 | -7.85 Million USD | 20.56% |
| 2019 Q3 | -9.88 Million USD | -33.24% |
| 2019 Q2 | -7.42 Million USD | 8.55% |
| 2019 FY | - USD | -179.6% |
| 2019 Q1 | -8.11 Million USD | -88.41% |
| 2018 Q2 | -1.69 Million USD | 38.72% |
| 2018 Q3 | -3.33 Million USD | -97.04% |
| 2018 Q4 | -4.3 Million USD | -29.34% |
| 2018 FY | - USD | 24.38% |
| 2018 Q1 | -2.75 Million USD | -92.87% |
| 2017 Q4 | -1.43 Million USD | 67.7% |
| 2017 Q1 | -5.27 Million USD | 0.0% |
| 2017 FY | - USD | 2.59% |
| 2017 Q2 | -4.39 Million USD | 16.64% |
| 2017 Q3 | -4.42 Million USD | -0.73% |
| 2016 Q1 | -6.25 Million USD | 0.0% |
| 2016 FY | - USD | 36.64% |
| 2015 Q1 | -6.68 Million USD | 13.02% |
| 2015 FY | - USD | 1.45% |
| 2014 Q1 | -3.47 Million USD | 0.0% |
| 2014 FY | - USD | -395.79% |
| 2014 Q4 | -7.68 Million USD | 0.0% |
| 2013 FY | - USD | 50.86% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -155.401% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 30.791% |
| Bioventus Inc. | -23.07 Million USD | -49.311% |
| BrainsWay Ltd. | -2.31 Million USD | -1390.524% |
| Cerus Corporation | -26.53 Million USD | -29.809% |
| Envoy Medical, Inc. | -18.23 Million USD | -88.869% |
| electroCore, Inc. | -17.76 Million USD | -93.953% |
| IceCure Medical Ltd | -15.25 Million USD | -125.831% |
| OrthoPediatrics Corp. | -8.38 Million USD | -311.001% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 30.763% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -104.358% |
| MaxCyte, Inc. | -44.12 Million USD | 21.941% |
| Nexalin Technology, Inc. | -5.69 Million USD | -505.161% |
| PAVmed Inc | -75.74 Million USD | 54.522% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -228.229% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 35.924% |
| RxSight, Inc. | -41.03 Million USD | 16.061% |
| Sight Sciences, Inc. | -49.41 Million USD | 30.292% |
| TELA Bio, Inc. | -40.63 Million USD | 15.227% |
| Talis Biomedical Corporation | -66.04 Million USD | 47.845% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 40.914% |
| Treace Medical Concepts, Inc. | -39 Million USD | 11.695% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -106.573% |
| Inogen, Inc. | -45.67 Million USD | 24.591% |
| Spectral AI, Inc. | -12.26 Million USD | -180.917% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 27.776% |
| CVRx, Inc. | -38.73 Million USD | 11.063% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -876.361% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -184.513% |
| Orthofix Medical Inc. | -86.98 Million USD | 60.4% |
| Venus Concept Inc. | -26.11 Million USD | -31.911% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -193.008% |
| LivaNova PLC | 39.01 Million USD | 188.287% |
| 908 Devices Inc. | -34.02 Million USD | -1.237% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 68.853% |
| Nemaura Medical Inc. | -7.28 Million USD | -372.701% |
| NeuroPace, Inc. | -22.83 Million USD | -50.854% |
| LENSAR, Inc. | -8.71 Million USD | -295.295% |
| Apyx Medical Corporation | -18.11 Million USD | -90.183% |
| Cutera, Inc. | -136.56 Million USD | 74.776% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -919.112% |
| BioSig Technologies, Inc. | -28.15 Million USD | -22.362% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1469.078% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -64.115% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 108.98% |
| Axonics, Inc. | 7.77 Million USD | 543.035% |
| Outset Medical, Inc. | -153.78 Million USD | 77.602% |
| IRIDEX Corporation | -7.44 Million USD | -362.487% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 64.885% |
| IRadimed Corporation | 20.8 Million USD | 265.601% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -327.264% |
| INVO Bioscience, Inc. | -6.88 Million USD | -400.667% |
| Telesis Bio, Inc. | -40.49 Million USD | 14.933% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 193.917% |
| Varex Imaging Corporation | 67.2 Million USD | 151.259% |
| Quipt Home Medical Corp. | 44.07 Million USD | 178.16% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -216.891% |
| Pulmonx Corporation | -55.09 Million USD | 37.475% |
| Dynatronics Corporation | -976 Thousand USD | -3429.274% |
| Modular Medical, Inc. | -17.1 Million USD | -101.403% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -137.805% |
| Semler Scientific, Inc. | 23.58 Million USD | 246.026% |
| InMode Ltd. | 196.28 Million USD | 117.549% |
| Bruker Corporation | 599 Million USD | 105.751% |
| Cytosorbents Corporation | -28.81 Million USD | -19.559% |
| DexCom, Inc. | 916.7 Million USD | 103.758% |
| Align Technology, Inc. | 799.03 Million USD | 104.311% |
| Viveve Medical, Inc. | -20.61 Million USD | -67.076% |
| ZimVie Inc. | 91.07 Million USD | 137.822% |
| Movano Inc. | -29.12 Million USD | -18.27% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -681.443% |
| Nexalin Technology, Inc. | -5.69 Million USD | -505.161% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -876.361% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 82.304% |
| Profound Medical Corp. | -27.12 Million USD | -26.997% |
| Insulet Corporation | 323.6 Million USD | 110.645% |
| enVVeno Medical Corporation | -25.01 Million USD | -37.685% |
| Surmodics, Inc. | 1.18 Million USD | 2999.495% |
| iCAD, Inc. | -6.56 Million USD | -424.692% |
| Nuwellis, Inc. | -16.35 Million USD | -110.602% |
| Biotricity, Inc. | -8.82 Million USD | -290.178% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 64.438% |
| Aethlon Medical, Inc. | -11.84 Million USD | -190.705% |
| InspireMD, Inc. | -20.91 Million USD | -64.727% |
| PAVmed Inc. | -75.74 Million USD | 54.522% |
| BIOLASE, Inc. | -15.13 Million USD | -127.532% |
| Beyond Air, Inc. | -59.03 Million USD | 41.648% |
| FONAR Corporation | 28.25 Million USD | 221.926% |
| AxoGen, Inc. | -13.32 Million USD | -158.448% |
| Vivani Medical, Inc. | -26.6 Million USD | -29.457% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 240.361% |
| Inari Medical, Inc. | 7.11 Million USD | 584.268% |
| UFP Technologies, Inc. | 72.74 Million USD | 147.353% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -917.371% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -459.552% |
| Tenon Medical, Inc. | -15.52 Million USD | -121.832% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -125.639% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 16.949% |
| AdaptHealth Corp. | -171.09 Million USD | 79.867% |
| Sintx Technologies, Inc. | -6.6 Million USD | -421.909% |
| NanoVibronix, Inc. | -3.43 Million USD | -902.795% |
| Quanterix Corporation | -38.08 Million USD | 9.562% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -216.891% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 114920.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 87.577% |
| TransMedics Group, Inc. | -7.6 Million USD | -353.058% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -58.263% |
| NeuroMetrix, Inc. | -7.09 Million USD | -385.441% |
| Hyperfine, Inc. | -47.06 Million USD | 26.806% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 40.923% |
| Biomerica, Inc. | -5.99 Million USD | -474.771% |
| Bone Biologics Corporation | 479.57 Thousand USD | 7282.655% |
| AVITA Medical, Inc. | -39.56 Million USD | 12.944% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -275.518% |
| Silk Road Medical, Inc | -45.08 Million USD | 23.589% |